Blog

Rachel Conklin, MMS, PA-C, Clinical Solutions Director at Everly Health

Authors
rachel headshot on dark green background
  • Master of Medical Science in Physician Assistant Studies
  • Certification in Clinical and Population Translational Science Research
  • Practicing Physician's Assistant
  • Clinical Solutions Director at Everly Health

Medical Expert Experience

Rachel Conklin, MMS, PA-C is a board-certified physician assistant and a healthcare leader in advanced practice gastroenterology and inflammatory bowel disease as well as clinical and telehealth program development. Rachel holds a BE in biomedical engineering from Vanderbilt University, and she received her Masters in PA studies, along with additional certification in clinical and population translational science, from Wake Forest School of Medicine. She is a member of the RN/APP National Scientific Advisory Committee of the Crohn's and Colitis Foundation and is a thought leader and speaker for Johnson and Johnson.

Education

  • Vanderbilt University
  • Wake Forest School of Medicine

Credentials and Certifications

  • Master of Medical Science in Physician Assistant Studies
  • B.A., Biomedical Engineering
  • Certification in Clinical and Population Translational Science Research

Skills

  • Clinical and telehealth program development
  • Enhancing patient care and improving healthcare delivery
  • Medical review of blog content
← What Are Signs of Elevated DHEA Hormone in Men?8 Of The Most Common Food Allergies Worth Knowing →

Spotlight on

Breast Cancer Awareness Month

Clairity Breast™

Your mammogram looks for cancer today. What about tomorrow? A new way to look at your breast cancer risk.

Learn more
Caris Detect™

When it comes to cancer, early is everything. Screen for early signs on 55+ cancers with a single blood draw.

Know early
Clairity Breast™

Your mammogram looks for cancer today. What about tomorrow? A new way to look at your breast cancer risk.

Learn more
Caris Detect™

When it comes to cancer, early is everything. Screen for early signs on 55+ cancers with a single blood draw.

Know early

Explore Everlywell

Top picks

Shop all products
New!Risk Assessment

Clairity Breast™ Cancer 5-Year Risk Assessment

FDA-authorized AI driven software analyzes your existing screening mammogram to estimate your 5-year breast cancer risk.

$249.00
Shop all products